Centaurus Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,822
| Closed | -$168K | – | 847 |
|
|
2024
Q2 | $168K | Buy |
1,822
+212
| +13% | +$19.5K | 0.01% | 649 |
|
|
2024
Q1 | $154K | Sell |
1,610
-149
| -8% | -$14.3K | 0.01% | 674 |
|
|
2023
Q4 | $134K | Sell |
1,759
-271
| -13% | -$20.6K | 0.01% | 688 |
|
|
2023
Q3 | $141K | Buy |
2,030
+673
| +50% | +$46.7K | 0.01% | 648 |
|
|
2023
Q2 | $128K | Sell |
1,357
-1,915
| -59% | -$181K | 0.01% | 677 |
|
|
2023
Q1 | $271K | Buy |
3,272
+797
| +32% | +$66K | 0.02% | 576 |
|
|
2022
Q4 | $185K | Sell |
2,475
-126
| -5% | -$9.42K | 0.02% | 628 |
|
|
2022
Q3 | $215K | Buy |
2,601
+177
| +7% | +$14.6K | 0.02% | 597 |
|
|
2022
Q2 | $230K | Buy |
+2,424
| New | +$230K | 0.02% | 561 |
|
|
2018
Q3 | – | Sell |
-2,352
| Closed | -$114K | – | 991 |
|
|
2018
Q2 | $114K | Buy |
+2,352
| New | +$114K | 0.02% | 667 |
|